Body mass index as a prognostic factor in epithelial ovarian cancer and correlation with clinico-pathological factors

References

• Shuk-Mei Ho. Estrogen, progesterone and epithelial ovarian cancer. Reprod Biol Endocrinol. 2003;1:73.
   Google Scholar
• Harlan LC, Clegg LX, Trimble EL. Trends in surgery and chemotherapy for women diagnosed with ovarian cancer in the United States. J Clin Oncol. 2003;21:3488–94.
   PubMed Web of Science ®Google Scholar
• Aletti GD, Gostout BS, Podratz KC, Cliby WA. Ovarian cancer surgical resectability: relative impact of disease, patient status, and surgeon. Gynecol Oncol. 2006;100: 31–7.
   Google Scholar
• Kjärbye-Thygesen A, Frederiksen K, Högdall EV, Glud E, Christensen L, Högdall CK. Smoking and overweight: negative prognostic factors in stage III epithelial ovarian cancer. Cancer Epidemiol, Biomarkers Prev. 2006;15:798–803.
   Google Scholar
• World Health Organization (WHO) Consultation on Obesity. Preventing and managing the global epidemic: Report of a WHO consultation on Obesity, Geneva, 3-5 June 1997, Geneva (Switzerland): WHO.1998:1-276
   Google Scholar
• Rodriquez C, Calle EE, Fakhrabadi-Shokoohi D, Jacobs EJ, Thun MJ. Body mass index, height, and the risk of ovarian cancer mortality in a prospective cohort of postmenopausal women. Cancer Epidemiol, Biomarkers Prev. 2002;11: 822–8.
   Google Scholar
• Calle EE, Rodriquez C, Walker-Thurmond K Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348: 1625–38.
   PubMed Web of Science ®Google Scholar
• Zhang M, Xie X, Lee AH, Binns CW, Holman CD`AJ. Body mass index in relation to ovarian cancer survival. Cancer Epidemiol, Biomarkers Prev. 2005;14: 1307-10.
   PubMedGoogle Scholar
• Pavelka JC, Brown RS, Karlan BY, Cass I, Leuchter RS, Lagasse LD, Effect of obesity on survival in epithelial ovarian cancer. Cancer. 2006;107:1520–4.
   Google Scholar
• Hess LM, Barakat R, Tian C, Ozols RF, Alberts DS. Weight change during chemotherapy as a potential prognostic factor for stage III epithelian ovarian carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 2007;107:260–5.
   PubMed Web of Science ®Google Scholar
• Barrett SV, Paul J, Hay A, Vasey PA, Kaye SB, Glasspool RM. Does body mass index affect progression-free or overall survival in patients with ovarian cancer? Results from SCOTROC I trial. Ann Oncol. 2008;19:898–902.
   PubMedGoogle Scholar
• Skirnisdottir I, Sorbe B. Prognostic impact of body mass index and effect of overweight and obesity on surgical and adjuvant treatment in early-stage epithelial ovarian cancer. Int J Gynecol Cancer. 2008;18:345–51.
   PubMedGoogle Scholar
• Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. Am Stat Assoc J. 1958;58:457–81.
   Google Scholar
• Engeland A, Tretli S, Björge T. Height, body mass index and ovarian cancer: A follow-up of 1.1 million Norwegian women. J Natl Cancer Instit. 2003;16:1244–8.
   Google Scholar
• Gil KM, Frasure HE, Hopkins MP, Jenison EL, von Grueningen VE. Body weight and composition changes in ovarian cancer patients during adjuvant chemotherapy. Gynecol Oncol. 2006;103:247–52.
   PubMedGoogle Scholar
• Olsen CM, Nagle CM, Whiteman DC, Purdie DM, Green AC, Webb PM; Australian cancer study group (Ovarian cancer) and Australian ovarian cancer study group. Int J Cancer. 2008;15:450-6
   Google Scholar
• Wolfberg AJ, Montz FJ, Bristow EB. Role of obesity in the surgical management of advanced-stage ovarian cancer. J Reprod Med. 2004;49:473–6.
   Google Scholar
• Dindo D, Muller MK, Weber M, Clavien PA. Obesity in general elective surgery. Lancet. 2003;361:2032–5.
   PubMed Web of Science ®Google Scholar
• Munstedt K, Wagner M, Kullmer U, Hackethal A, Francke FE. Cancer Causes Control; 2008.
   Google Scholar
• Vergote I, Brabanter JD, Fyles A, Bertelsen K, Sevelda NEP, Gore ME, Progostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma. Lancet. 2001;357:176–82.
   PubMed Web of Science ®Google Scholar
• Kristensen GB, Kildal W, Abeler VM, Kaern J, Vergote I, Tropé CG, Large-scale genomic instability predicts long-term outcome for women with invasive stage I ovarian cancer. Ann Oncol. 2003;14:1494–500.
   Google Scholar